{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T01:55:49Z","timestamp":1783734949279,"version":"3.55.0"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:00:00Z","timestamp":1673481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:00:00Z","timestamp":1673481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["Canada Graduate Scholarship Doctoral"],"award-info":[{"award-number":["Canada Graduate Scholarship Doctoral"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP 89825"],"award-info":[{"award-number":["MOP 89825"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PRJ 153101"],"award-info":[{"award-number":["PRJ 153101"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ontario Graduate Scholarship"},{"name":"Ontario Graduate Scholarships International"},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cholinergic synapses in prefrontal cortex are vital for attention, but this modulatory system undergoes substantial pre- and post-synaptic alterations during adulthood. To examine the integrated impact of these changes, we optophysiologically probe cholinergic synapses ex vivo, revealing a clear decline in neurotransmission in middle adulthood. Pharmacological dissection of synaptic components reveals a selective reduction in postsynaptic nicotinic receptor currents. Other components of cholinergic synapses appear stable, by contrast, including acetylcholine autoinhibition, metabolism, and excitation of postsynaptic muscarinic receptors. Pursuing strategies to strengthen cholinergic neurotransmission, we find that positive allosteric modulation of nicotinic receptors with NS9283 is effective in young adults but wanes with age. To boost nicotinic receptor availability, we harness the second messenger pathways of the preserved excitatory muscarinic receptors with xanomeline. This muscarinic agonist and cognitive-enhancer restores nicotinic signaling in older mice significantly, in a muscarinic- and PKC-dependent manner. The rescued nicotinic component regains youthful sensitivity to allosteric enhancement: treatment with xanomeline and NS9283 restores cholinergic synapses in older mice to the strength, speed, and receptor mechanism of young adults. Our results reveal a new and efficient strategy to rescue age-related nicotinic signaling deficits, demonstrating a novel pathway for xanomeline to restore cognitively-essential endogenous cholinergic neurotransmission.<\/jats:p>","DOI":"10.1038\/s41386-023-01531-5","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T09:13:01Z","timestamp":1673514781000},"page":"671-682","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Xanomeline restores endogenous nicotinic acetylcholine receptor signaling in mouse prefrontal cortex"],"prefix":"10.1038","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9034-1025","authenticated-orcid":false,"given":"Saige K.","family":"Power","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sridevi","family":"Venkatesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5994-6090","authenticated-orcid":false,"given":"Evelyn K.","family":"Lambe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,12]]},"reference":[{"key":"1531_CR1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1207\/s15324826an0101&2_6","volume":"1","author":"CM Filley","year":"1994","unstructured":"Filley CM, Cullum CM. Attention and vigilance functions in normal aging. Appl Neuropsychol. 1994;1:29\u201332.","journal-title":"Appl Neuropsychol"},{"key":"1531_CR2","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.acn.2004.12.008","volume":"20","author":"TM Mani","year":"2005","unstructured":"Mani TM, Bedwell JS, Miller LS. Age-related decrements in performance on a brief continuous performance test. Arch Clin Neuropsychol. 2005;20:575\u201386.","journal-title":"Arch Clin Neuropsychol"},{"key":"1531_CR3","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1080\/0361073X.2010.484729","volume":"36","author":"N Gamboz","year":"2010","unstructured":"Gamboz N, Zamarian S, Cavallero C. Age-related differences in the attention network test (ANT). Exp Aging Res. 2010;36:287\u2013305.","journal-title":"Exp Aging Res"},{"key":"1531_CR4","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3389\/fnagi.2016.00099","volume":"8","author":"DAS Kaufman","year":"2016","unstructured":"Kaufman DAS, Sozda CN, Dotson VM, Perlstein WM. An Event-Related Potential Investigation of the Effects of Age on Alerting, Orienting, and Executive Function. Front Aging Neurosci. 2016;8:99.","journal-title":"Front Aging Neurosci"},{"key":"1531_CR5","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.bandc.2010.12.003","volume":"75","author":"S Zhou","year":"2011","unstructured":"Zhou S, Fan J, Lee TMC, Wang C, Wang K. Age-related differences in attentional networks of alerting and executive control in young, middle-aged, and older Chinese adults. Brain Cogn. 2011;75:205\u201310.","journal-title":"Brain Cogn"},{"key":"1531_CR6","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1093\/cercor\/bhr172","volume":"22","author":"T Hedden","year":"2012","unstructured":"Hedden T, Van Dijk KRA, Shire EH, Sperling RA, Johnson KA, Buckner RL. Failure to Modulate Attentional Control in Advanced Aging Linked to White Matter Pathology. Cereb Cortex. 2012;22:1038\u201351.","journal-title":"Cereb Cortex"},{"key":"1531_CR7","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1093\/cercor\/bhh052","volume":"14","author":"JW Dalley","year":"2004","unstructured":"Dalley JW, Theobald DE, Bouger P, Chudasama Y, Cardinal RN, Robbins TW. Cortical cholinergic function and deficits in visual attentional performance in rats following 192 IgG-saporin-induced lesions of the medial prefrontal cortex. Cereb Cortex 2004;14:922\u201332.","journal-title":"Cereb Cortex"},{"key":"1531_CR8","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1046\/j.1460-9568.2000.00183.x","volume":"12","author":"F Passetti","year":"2000","unstructured":"Passetti F, Dalley JW, O\u2019Connell MT, Everitt BJ, Robbins TW. Increased acetylcholine release in the rat medial prefrontal cortex during performance of a visual attentional task. Eur J Neurosci. 2000;12:3051\u20138.","journal-title":"Eur J Neurosci"},{"key":"1531_CR9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.neuron.2007.08.025","volume":"56","author":"V Parikh","year":"2007","unstructured":"Parikh V, Kozak R, Martinez V, Sarter M. Prefrontal acetylcholine release controls cue detection on multiple time scales. Neuron 2007;56:141\u201354.","journal-title":"Neuron"},{"key":"1531_CR10","doi-asserted-by":"publisher","first-page":"E1089","DOI":"10.1073\/pnas.1516134113","volume":"113","author":"HJ Gritton","year":"2016","unstructured":"Gritton HJ, Howe WM, Mallory CS, Hetrick VL, Berke JD, Sarter M. Cortical cholinergic signaling controls the detection of cues. Proc Natl Acad Sci. 2016;113:E1089\u2013E1097.","journal-title":"Proc Natl Acad Sci"},{"key":"1531_CR11","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1523\/JNEUROSCI.2737-16.2017","volume":"37","author":"WM Howe","year":"2017","unstructured":"Howe WM, Gritton HJ, Lusk NA, Roberts EA, Hetrick VL, Berke JD, et al. Acetylcholine Release in Prefrontal Cortex Promotes Gamma Oscillations and Theta\u2013Gamma Coupling during Cue Detection. J Neurosci. 2017;37:3215\u201330.","journal-title":"J Neurosci"},{"key":"1531_CR12","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1126\/science.7046051","volume":"217","author":"RT Bartus","year":"1982","unstructured":"Bartus RT, Dean RL, Beer B, Lippa AS. The Cholinergic Hypothesis of Geriatric Memory Dysfunction. Science 1982;217:408\u201317.","journal-title":"Science"},{"key":"1531_CR13","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.pbb.2011.02.022","volume":"99","author":"JA Dumas","year":"2011","unstructured":"Dumas JA, Newhouse PA. The Cholinergic Hypothesis of Cognitive Aging Revisited Again: Cholinergic Functional Compensation. Pharm Biochem Behav. 2011;99:254\u201361.","journal-title":"Pharm Biochem Behav"},{"key":"1531_CR14","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0959-4388(95)80022-0","volume":"5","author":"M Gallagher","year":"1995","unstructured":"Gallagher M, Colombo PJ. Ageing: the cholinergic hypothesis of cognitive decline. Curr Opin Neurobiol. 1995;5:161\u20138.","journal-title":"Curr Opin Neurobiol"},{"key":"1531_CR15","first-page":"27","volume":"23","author":"H Hanyu","year":"2002","unstructured":"Hanyu H, Asano T, Sakurai H, Tanaka Y, Takasaki M, Abe K. MR analysis of the substantia innominata in normal aging, Alzheimer disease, and other types of dementia. AJNR Am J Neuroradiol. 2002;23:27\u201332.","journal-title":"AJNR Am J Neuroradiol"},{"key":"1531_CR16","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1001\/archneur.64.9.1312","volume":"64","author":"MD Ikonomovic","year":"2007","unstructured":"Ikonomovic MD, Abrahamson EE, Isanski BA, Wuu J, Mufson EJ, DeKosky ST. Superior frontal cortex cholinergic axon density in mild cognitive impairment and early Alzheimer disease. Arch Neurol. 2007;64:1312\u20137.","journal-title":"Arch Neurol"},{"key":"1531_CR17","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/j.neurobiolaging.2007.12.008","volume":"30","author":"EM Mitsis","year":"2009","unstructured":"Mitsis EM, Cosgrove KP, Staley JK, Bois F, Frohlich EB, Tamagnan GD, et al. Age-related decline in nicotinic receptor availability with [123I]5-IA-85380 SPECT. Neurobiol Aging. 2009;30:1490\u20137.","journal-title":"Neurobiol Aging"},{"key":"1531_CR18","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00259-010-1644-5","volume":"38","author":"K Kendziorra","year":"2011","unstructured":"Kendziorra K, Wolf H, Meyer PM, Barthel H, Hesse S, Becker GA, et al. Decreased cerebral \u03b14\u03b22* nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer\u2019s disease assessed with positron emission tomography. Eur J Nucl Med Mol Imaging. 2011;38:515\u201325.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1531_CR19","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/jnr.490270418","volume":"27","author":"SL Dewey","year":"1990","unstructured":"Dewey SL, Volkow ND, Logan J, MacGregor RR, Fowler JS, Schlyer DJ, et al. Age-related decreases in muscarinic cholinergic receptor binding in the human brain measured with positron emission tomography (PET). J Neurosci Res. 1990;27:569\u201375.","journal-title":"J Neurosci Res"},{"key":"1531_CR20","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.brainres.2008.09.038","volume":"1243","author":"F Pilar-Cu\u00e9llar","year":"2008","unstructured":"Pilar-Cu\u00e9llar F, Paniagua MA, D\u00edez-Alarcia R, Dos Anjos S, Montori S, P\u00e9rez CC, et al. Muscarinic receptor changes in the gerbil thalamus during aging. Brain Res. 2008;1243:38\u201346.","journal-title":"Brain Res"},{"key":"1531_CR21","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1124\/jpet.102.041616","volume":"306","author":"AV Terry","year":"2003","unstructured":"Terry AV, Buccafusco JJ. The cholinergic hypothesis of age and Alzheimer\u2019s disease-related cognitive deficits: recent challenges and their implications for novel drug development. J Pharm Exp Ther. 2003;306:821\u20137.","journal-title":"J Pharm Exp Ther"},{"key":"1531_CR22","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1093\/cercor\/bhx047","volume":"28","author":"M Janeczek","year":"2018","unstructured":"Janeczek M, Gefen T, Samimi M, Kim G, Weintraub S, Bigio E, et al. Variations in Acetylcholinesterase Activity within Human Cortical Pyramidal Neurons Across Age and Cognitive Trajectories. Cereb Cortex 2018;28:1329\u201337.","journal-title":"Cereb Cortex"},{"key":"1531_CR23","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.physbeh.2005.12.011","volume":"87","author":"DV Poltavski","year":"2006","unstructured":"Poltavski DV, Petros T. Effects of transdermal nicotine on attention in adult non-smokers with and without attentional deficits. Physiol Behav. 2006;87:614\u201324.","journal-title":"Physiol Behav"},{"key":"1531_CR24","doi-asserted-by":"crossref","unstructured":"Howe WM, Ji J, Parikh V, Williams S, Moca\u00ebr E, Trocm\u00e9-Thibierge C. et al. Enhancement of attentional performance by selective stimulation of alpha4beta2(*) nAChRs: underlying cholinergic mechanisms. Neuropsychopharmacol. 2010;35:1391\u2013401.","DOI":"10.1038\/npp.2010.9"},{"key":"1531_CR25","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1001\/archgenpsychiatry.2011.83","volume":"68","author":"LE Hong","year":"2011","unstructured":"Hong LE, Thaker GK, McMahon RP, Summerfelt A, Rachbeisel J, Fuller RL, et al. Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder. Arch Gen Psychiatry. 2011;68:1195\u2013206.","journal-title":"Arch Gen Psychiatry"},{"key":"1531_CR26","first-page":"12","volume":"20","author":"SH Preskorn","year":"2014","unstructured":"Preskorn SH, Gawryl M, Dgetluck N, Palfreyman M, Bauer LO, Hilt DC. Normalizing effects of EVP-6124, an \u03b1-7 nicotinic partial agonist, on event-related potentials and cognition: a proof of concept, randomized trial in patients with schizophrenia. J Psychiatr Pr. 2014;20:12\u201324.","journal-title":"J Psychiatr Pr"},{"key":"1531_CR27","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1001\/archneur.1997.00550160091022","volume":"54","author":"NC Bodick","year":"1997","unstructured":"Bodick NC, Offen WW, Levey AI, Cutler NR, Gauthier SG, Satlin A, et al. Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease. Arch Neurol. 1997;54:465\u201373.","journal-title":"Arch Neurol"},{"key":"1531_CR28","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1176\/appi.ajp.2008.06091591","volume":"165","author":"A Shekhar","year":"2008","unstructured":"Shekhar A, Potter WZ, Lightfoot J, Lienemann J, Dub\u00e9 S, Mallinckrodt C, et al. Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia. Am J Psychiatry. 2008;165:1033\u20139.","journal-title":"Am J Psychiatry"},{"key":"1531_CR29","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1056\/NEJMoa2017015","volume":"384","author":"SK Brannan","year":"2021","unstructured":"Brannan SK, Sawchak S, Miller AC, Lieberman JA, Paul SM, Breier A. Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophrenia. N Engl J Med. 2021;384:717\u201326.","journal-title":"N Engl J Med"},{"key":"1531_CR30","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1212\/01.WNL.0000134664.80320.92","volume":"63","author":"S Salloway","year":"2004","unstructured":"Salloway S, Ferris S, Kluger A, Goldman R, Griesing T, Kumar D, et al. Donepezil 401 Study Group. Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial. Neurology 2004;63:651\u20137.","journal-title":"Neurology"},{"key":"1531_CR31","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1212\/01.wnl.0000344650.95823.03","volume":"72","author":"RS Doody","year":"2009","unstructured":"Doody RS, Ferris SH, Salloway S, Sun Y, Goldman R, Watkins WE, et al. Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial. Neurology 2009;72:1555\u201361.","journal-title":"Neurology"},{"key":"1531_CR32","doi-asserted-by":"publisher","first-page":"9148650","DOI":"10.1155\/2022\/9148650","volume":"2022","author":"X Fang","year":"2022","unstructured":"Fang X, Zhang J, Zhao J, Wang L. Effect of Resveratrol Combined with Donepezil Hydrochloride on Inflammatory Factor Level and Cognitive Function Level of Patients with Alzheimer\u2019s Disease. J Health Eng. 2022;2022:9148650.","journal-title":"J Health Eng"},{"key":"1531_CR33","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1093\/gerona\/glaa285","volume":"76","author":"DL Palliyaguru","year":"2021","unstructured":"Palliyaguru DL, Vieira Ligo Teixeira C, Duregon E, di Germanio C, Alfaras I, Mitchell SJ, et al. Study of Longitudinal Aging in Mice: Presentation of Experimental Techniques. J Gerontol Ser A. 2021;76:552\u201360.","journal-title":"J Gerontol Ser A."},{"key":"1531_CR34","doi-asserted-by":"crossref","unstructured":"Yanai S, Endo S. Functional Aging in Male C57BL\/6J Mice Across the Life-Span: A Systematic Behavioral Analysis of Motor, Emotional, and Memory Function to Define an Aging Phenotype. Front Aging Neurosci. 2021;13:97621.","DOI":"10.3389\/fnagi.2021.697621"},{"key":"1531_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-016-0191-9","volume":"9","author":"H Shoji","year":"2016","unstructured":"Shoji H, Takao K, Hattori S, Miyakawa T. Age-related changes in behavior in C57BL\/6J mice from young adulthood to middle age. Mol Brain. 2016;9:11.","journal-title":"Mol Brain"},{"key":"1531_CR36","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1152\/jn.00716.2014","volume":"113","author":"T Hedrick","year":"2015","unstructured":"Hedrick T, Waters J. Acetylcholine excites neocortical pyramidal neurons via nicotinic receptors. J Neurophysiol. 2015;113:2195\u2013209.","journal-title":"J Neurophysiol"},{"key":"1531_CR37","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1093\/cercor\/bhv085","volume":"26","author":"YA Hay","year":"2016","unstructured":"Hay YA, Lambolez B, Tricoire L. Nicotinic Transmission onto Layer 6 Cortical Neurons Relies on Synaptic Activation of Non-\u03b17 Receptors. Cereb Cortex 2016;26:2549\u201362.","journal-title":"Cereb Cortex"},{"key":"1531_CR38","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fncir.2017.00107","volume":"11","author":"DW Sparks","year":"2017","unstructured":"Sparks DW, Tian MK, Sargin D, Venkatesan S, Intson K, Lambe EK. Opposing Cholinergic and Serotonergic Modulation of Layer 6 in Prefrontal Cortex. Front Neural Circuits. 2017;11:107.","journal-title":"Front Neural Circuits"},{"key":"1531_CR39","doi-asserted-by":"publisher","first-page":"7255","DOI":"10.1523\/JNEUROSCI.1128-20.2020","volume":"40","author":"S Venkatesan","year":"2020","unstructured":"Venkatesan S, Lambe EK. Chrna5 is Essential for a Rapid and Protected Response to Optogenetic Release of Endogenous Acetylcholine in Prefrontal Cortex. J Neurosci. 2020;40:7255\u201368.","journal-title":"J Neurosci"},{"key":"1531_CR40","doi-asserted-by":"publisher","first-page":"5724","DOI":"10.1523\/JNEUROSCI.0093-20.2020","volume":"40","author":"M Ghimire","year":"2020","unstructured":"Ghimire M, Cai R, Ling L, Hackett TA, Caspary DM. Nicotinic Receptor Subunit Distribution in Auditory Cortex: Impact of Aging on Receptor Number and Function. J Neurosci. 2020;40:5724\u201339.","journal-title":"J Neurosci"},{"key":"1531_CR41","doi-asserted-by":"crossref","unstructured":"Patel AV, Codeluppi SA, Ervin KSJ, St-Denis MB, Choleris E, Bailey CDC. Developmental Age and Biological Sex Influence Muscarinic Receptor Function and Neuron Morphology within Layer VI of the Medial Prefrontal Cortex. Cereb Cortex. 2021;32:3137\u201358.","DOI":"10.1093\/cercor\/bhab406"},{"key":"1531_CR42","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1152\/jn.00493.2006","volume":"97","author":"AT Gulledge","year":"2007","unstructured":"Gulledge AT, Park SB, Kawaguchi Y, Stuart GJ. Heterogeneity of phasic cholinergic signaling in neocortical neurons. J Neurophysiol. 2007;97:2215\u201329.","journal-title":"J Neurophysiol"},{"key":"1531_CR43","doi-asserted-by":"publisher","first-page":"16458","DOI":"10.1523\/JNEUROSCI.3600-11.2011","volume":"31","author":"MK Tian","year":"2011","unstructured":"Tian MK, Bailey CDC, De Biasi M, Picciotto MR, Lambe EK. Plasticity of prefrontal attention circuitry: upregulated muscarinic excitability in response to decreased nicotinic signaling following deletion of \u03b15 or \u03b22 subunits. J Neurosci. 2011;31:16458\u201363.","journal-title":"J Neurosci"},{"key":"1531_CR44","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1111\/ejn.12622","volume":"40","author":"MK Tian","year":"2014","unstructured":"Tian MK, Bailey CDC, Lambe EK. Cholinergic excitation in mouse primary vs. associative cortex: region-specific magnitude and receptor balance. Eur J Neurosci. 2014;40:2608\u201318.","journal-title":"Eur J Neurosci"},{"key":"1531_CR45","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/nmeth.1668","volume":"8","author":"S Zhao","year":"2011","unstructured":"Zhao S, Ting JT, Atallah HE, Qiu L, Tan J, Gloss B, et al. Cell-type Specific Optogenetic Mice for Dissecting Neural Circuitry Function. Nat Methods. 2011;8:745\u201352.","journal-title":"Nat Methods"},{"key":"1531_CR46","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/cne.24753","volume":"528","author":"N Nasirova","year":"2020","unstructured":"Nasirova N, Quina LA, Agosto-Marlin IM, Ramirez J-M, Lambe EK, Turner EE. Dual recombinase fate mapping reveals a transient cholinergic phenotype in multiple populations of developing glutamatergic neurons. J Comp Neurol. 2020;528:283\u2013307.","journal-title":"J Comp Neurol"},{"key":"1531_CR47","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0361-9230(01)00740-7","volume":"57","author":"E Tassonyi","year":"2002","unstructured":"Tassonyi E, Charpantier E, Muller D, Dumont L, Bertrand D. The role of nicotinic acetylcholine receptors in the mechanisms of anesthesia. Brain Res Bull. 2002;57:133\u201350.","journal-title":"Brain Res Bull"},{"key":"1531_CR48","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1213\/ANE.0b013e3181c5f689","volume":"110","author":"K Solt","year":"2010","unstructured":"Solt K, Kelly EW, Cotten JF, Raines DE. Inhibition of human alpha4beta2 neuronal nicotinic acetylcholine receptors by volatile aromatic anesthetics depends on drug hydrophobicity. Anesth Analg. 2010;110:455\u201360.","journal-title":"Anesth Analg"},{"key":"1531_CR49","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.14336\/AD.2019.1029","volume":"11","author":"J Zhong","year":"2020","unstructured":"Zhong J, Li J, Miao C, Zuo Z. A Novel Individual-based Determination of Postoperative Cognitive Dysfunction in Mice. Aging Dis. 2020;11:1133\u201345.","journal-title":"Aging Dis"},{"key":"1531_CR50","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/s41593-020-0648-0","volume":"23","author":"T Laszlovszky","year":"2020","unstructured":"Laszlovszky T, Schlingloff D, Heged\u00fcs P, Freund TF, Guly\u00e1s A, Kepecs A, et al. Distinct synchronization, cortical coupling and behavioral function of two basal forebrain cholinergic neuron types. Nat Neurosci. 2020;23:992\u20131003.","journal-title":"Nat Neurosci"},{"key":"1531_CR51","doi-asserted-by":"publisher","first-page":"4365","DOI":"10.1523\/JNEUROSCI.0178-05.2005","volume":"25","author":"MG Lee","year":"2005","unstructured":"Lee MG, Hassani OK, Alonso A, Jones BE. Cholinergic Basal Forebrain Neurons Burst with Theta during Waking and Paradoxical Sleep. J Neurosci. 2005;25:4365\u20139.","journal-title":"J Neurosci"},{"key":"1531_CR52","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3389\/fnbeh.2012.00021","volume":"6","author":"CT Unal","year":"2012","unstructured":"Unal CT, Golowasch JP, Zaborszky L. Adult mouse basal forebrain harbors two distinct cholinergic populations defined by their electrophysiology. Front Behav Neurosci. 2012;6:21.","journal-title":"Front Behav Neurosci"},{"key":"1531_CR53","doi-asserted-by":"publisher","first-page":"e9261","DOI":"10.1371\/journal.pone.0009261","volume":"5","author":"NC Alves","year":"2010","unstructured":"Alves NC, Bailey CDC, Nashmi R, Lambe EK. Developmental Sex Differences in Nicotinic Currents of Prefrontal Layer VI Neurons in Mice and Rats. PLOS ONE. 2010;5:e9261.","journal-title":"PLOS ONE"},{"key":"1531_CR54","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s12031-010-9377-2","volume":"41","author":"DA Brown","year":"2010","unstructured":"Brown DA. Muscarinic acetylcholine receptors (mAChRs) in the nervous system: some functions and mechanisms. J Mol Neurosci. 2010;41:340\u20136.","journal-title":"J Mol Neurosci."},{"key":"1531_CR55","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0304-3940(00)01163-0","volume":"287","author":"L Iannazzo","year":"2000","unstructured":"Iannazzo L, Majewski H. M(2)\/M(4)-muscarinic receptors mediate automodulation of acetylcholine outflow from mouse cortex. Neurosci Lett. 2000;287:129\u201332.","journal-title":"Neurosci Lett"},{"key":"1531_CR56","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1523\/JNEUROSCI.22-05-01709.2002","volume":"22","author":"W Zhang","year":"2002","unstructured":"Zhang W, Basile AS, Gomeza J, Volpicelli LA, Levey AI, Wess J. Characterization of central inhibitory muscarinic autoreceptors by the use of muscarinic acetylcholine receptor knock-out mice. J Neurosci. 2002;22:1709\u201317.","journal-title":"J Neurosci"},{"key":"1531_CR57","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S0014-4886(03)00094-3","volume":"182","author":"J Bu","year":"2003","unstructured":"Bu J. Age-related changes in calbindin-D28k, calretinin, and parvalbumin-immunoreactive neurons in the human cerebral cortex. Exp Neurol. 2003;182:220\u201331.","journal-title":"Exp Neurol"},{"key":"1531_CR58","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.neuropharm.2013.12.008","volume":"79","author":"M Grupe","year":"2014","unstructured":"Grupe M, Grunnet M, Laursen B, Bastlund JF. Neuropharmacological modulation of the P3-like event-related potential in a rat two-tone auditory discrimination task with modafinil and NS9283, a positive allosteric modulator of \u03b14\u03b22 nAChRs. Neuropharmacology 2014;79:444\u201355.","journal-title":"Neuropharmacology"},{"key":"1531_CR59","doi-asserted-by":"publisher","first-page":"24911","DOI":"10.1074\/jbc.M114.568097","volume":"289","author":"JA Olsen","year":"2014","unstructured":"Olsen JA, Ahring PK, Kastrup JS, Gajhede M, Balle T. Structural and Functional Studies of the Modulator NS9283 Reveal Agonist-like Mechanism of Action at \u03b14\u03b22 Nicotinic Acetylcholine Receptors. J Biol Chem. 2014;289:24911\u201321.","journal-title":"J Biol Chem"},{"key":"1531_CR60","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1476-5381.2012.01989.x","volume":"167","author":"D Timmermann","year":"2012","unstructured":"Timmermann D, Sandager-Nielsen K, Dyhring T, Smith M, Jacobsen A-M, Nielsen E, et al. Augmentation of cognitive function by NS9283, a stoichiometry-dependent positive allosteric modulator of \u03b12- and \u03b14-containing nicotinic acetylcholine receptors. Br J Pharm. 2012;167:164\u201382.","journal-title":"Br J Pharm"},{"key":"1531_CR61","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.neuron.2006.01.020","volume":"49","author":"A Caccamo","year":"2006","unstructured":"Caccamo A, Oddo S, Billings LM, Green KN, Martinez-Coria H, Fisher A, et al. M1 Receptors Play a Central Role in Modulating AD-like Pathology in Transgenic Mice. Neuron 2006;49:671\u201382.","journal-title":"Neuron"},{"key":"1531_CR62","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1093\/cercor\/bhp161","volume":"20","author":"CC Huang","year":"2010","unstructured":"Huang CC, Hsu KS. Activation of muscarinic acetylcholine receptors induces a nitric oxide-dependent long-term depression in rat medial prefrontal cortex. Cereb Cortex 2010;20:982\u201396.","journal-title":"Cereb Cortex"},{"key":"1531_CR63","doi-asserted-by":"publisher","first-page":"109434","DOI":"10.1016\/j.cellsig.2019.109434","volume":"65","author":"H Matsuoka","year":"2020","unstructured":"Matsuoka H, Harada K, Mashima K, Inoue M. Muscarinic receptor stimulation induces TASK1 channel endocytosis through a PKC-Pyk2-Src pathway in PC12 cells. Cell Signal. 2020;65:109434.","journal-title":"Cell Signal"},{"key":"1531_CR64","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1124\/mol.52.3.524","volume":"52","author":"M Gopalakrishnan","year":"1997","unstructured":"Gopalakrishnan M, Molinari EJ, Sullivan JP. Regulation of human alpha4beta2 neuronal nicotinic acetylcholine receptors by cholinergic channel ligands and second messenger pathways. Mol Pharm. 1997;52:524\u201334.","journal-title":"Mol Pharm"},{"key":"1531_CR65","doi-asserted-by":"publisher","first-page":"11554","DOI":"10.1523\/JNEUROSCI.23-37-11554.2003","volume":"23","author":"R Nashmi","year":"2003","unstructured":"Nashmi R, Dickinson ME, McKinney S, Jareb M, Labarca C, Fraser SE, et al. Assembly of alpha4beta2 nicotinic acetylcholine receptors assessed with functional fluorescently labeled subunits: effects of localization, trafficking, and nicotine-induced upregulation in clonal mammalian cells and in cultured midbrain neurons. J Neurosci. 2003;23:11554\u201367.","journal-title":"J Neurosci"},{"key":"1531_CR66","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1038\/sj.bjp.0702463","volume":"126","author":"MD Wood","year":"1999","unstructured":"Wood MD, Murkitt KL, Ho M, Watson JM, Brown F, Hunter AJ, et al. Functional comparison of muscarinic partial agonists at muscarinic receptor subtypes hM1, hM2, hM3, hM4 and hM5 using microphysiometry. Br J Pharmacol. 1999;126:1620\u20134.","journal-title":"Br J Pharmacol."},{"key":"1531_CR67","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/0197-4580(89)90040-7","volume":"10","author":"A Biegon","year":"1989","unstructured":"Biegon A, Hanau M, Greenberger V, Segal M. Aging and brain cholinergic muscarinic receptor subtypes: an autoradiographic study in the rat. Neurobiol Aging. 1989;10:305\u201310.","journal-title":"Neurobiol Aging"},{"key":"1531_CR68","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1523\/JNEUROSCI.10-09-03069.1990","volume":"10","author":"DM Araujo","year":"1990","unstructured":"Araujo DM, Lapchak PA, Meaney MJ, Collier B, Quirion R. Effects of aging on nicotinic and muscarinic autoreceptor function in the rat brain: relationship to presynaptic cholinergic markers and binding sites. J Neurosci. 1990;10:3069\u201378.","journal-title":"J Neurosci"},{"key":"1531_CR69","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/0306-4522(95)00572-2","volume":"72","author":"D Mitsushima","year":"1996","unstructured":"Mitsushima D, Mizuno T, Kimura F. Age-related changes in diurnal acetylcholine release in the prefrontal cortex of male rats as measured by microdialysis. Neuroscience 1996;72:429\u201334.","journal-title":"Neuroscience"},{"key":"1531_CR70","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0197-4580(99)00015-9","volume":"20","author":"R Ferrari","year":"1999","unstructured":"Ferrari R, Pedrazzi P, Algeri S, Agnati LF, Zoli M. Subunit and region-specific decreases in nicotinic acetylcholine receptor mRNA in the aged rat brain. Neurobiol Aging. 1999;20:37\u201346.","journal-title":"Neurobiol Aging"},{"key":"1531_CR71","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/S0024-3205(01)00950-X","volume":"68","author":"A Das","year":"2001","unstructured":"Das A, Dikshit M, Nath C. Profile of acetylcholinesterase in brain areas of male and female rats of adult and old age. Life Sci. 2001;68:1545\u201355.","journal-title":"Life Sci"},{"key":"1531_CR72","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.neuroscience.2003.09.028","volume":"124","author":"E Tribollet","year":"2004","unstructured":"Tribollet E, Bertrand D, Marguerat A, Raggenbass M. Comparative distribution of nicotinic receptor subtypes during development, adulthood and aging: an autoradiographic study in the rat brain. Neuroscience 2004;124:405\u201320.","journal-title":"Neuroscience"},{"key":"1531_CR73","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.neurobiolaging.2004.09.007","volume":"26","author":"M D\u00e9cossas","year":"2005","unstructured":"D\u00e9cossas M, Doudnikoff \u00c9, Bloch B, Bernard V. Aging and subcellular localization of m2 muscarinic autoreceptor in basalocortical neurons in vivo. Neurobiol Aging. 2005;26:1061\u201372.","journal-title":"Neurobiol Aging"},{"key":"1531_CR74","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1080\/15376516.2017.1349849","volume":"27","author":"V Strauss","year":"2017","unstructured":"Strauss V, Rey Moreno MC, Vogt J, Dammann M, Schneider S, Gr\u00f6ters S, et al. Acetylcholinesterase measurement in various brain regions and muscles of juvenile, adolescent, and adult rats. Toxicol Mech Methods. 2017;27:666\u201376.","journal-title":"Toxicol Mech Methods"},{"key":"1531_CR75","doi-asserted-by":"publisher","first-page":"4825","DOI":"10.1523\/JNEUROSCI.18-13-04825.1998","volume":"18","author":"SW Rogers","year":"1998","unstructured":"Rogers SW, Gahring LC, Collins AC, Marks M. Age-Related Changes in Neuronal Nicotinic Acetylcholine Receptor Subunit \u03b14 Expression Are Modified by Long-Term Nicotine Administration. J Neurosci. 1998;18:4825\u201332.","journal-title":"J Neurosci"},{"key":"1531_CR76","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0006-8993(98)00558-7","volume":"801","author":"A Marutle","year":"1998","unstructured":"Marutle A, Warpman U, Bogdanovic N, Nordberg A. Regional distribution of subtypes of nicotinic receptors in human brain and effect of aging studied by (+\/-)-[3H]epibatidine. Brain Res. 1998;801:143\u20139.","journal-title":"Brain Res."},{"key":"1531_CR77","doi-asserted-by":"publisher","first-page":"9888","DOI":"10.1523\/JNEUROSCI.1366-09.2009","volume":"29","author":"AT Gulledge","year":"2009","unstructured":"Gulledge AT, Bucci DJ, Zhang SS, Matsui M, Yeh HH. M1 Receptors Mediate Cholinergic Modulation of Excitability in Neocortical Pyramidal Neurons. J Neurosci. 2009;29:9888\u2013902.","journal-title":"J Neurosci"},{"key":"1531_CR78","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.biopsych.2013.10.017","volume":"76","author":"\u00c9 Proulx","year":"2014","unstructured":"Proulx \u00c9, Suri D, Heximer SP, Vaidya VA, Lambe EK. Early stress prevents the potentiation of muscarinic excitation by calcium release in adult prefrontal cortex. Biol Psychiatry. 2014;76:315\u201323.","journal-title":"Biol Psychiatry"},{"key":"1531_CR79","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1113\/JP275194","volume":"596","author":"AL Baker","year":"2018","unstructured":"Baker AL, O\u2019Toole RJ, Gulledge AT. Preferential cholinergic excitation of corticopontine neurons. J Physiol. 2018;596:1659\u201379.","journal-title":"J Physiol"},{"key":"1531_CR80","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/0006-291X(76)90975-X","volume":"72","author":"TC James","year":"1976","unstructured":"James TC, Kanungo MS. Alterations in atropine sites of the brain of rats as a function of age. Biochem Biophys Res Commun. 1976;72:170\u20135.","journal-title":"Biochem Biophys Res Commun"},{"key":"1531_CR81","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/BF00964618","volume":"5","author":"AM Morin","year":"1980","unstructured":"Morin AM, Wasterlain CG. Aging and rat brain muscarinic receptors as measured by quinuclidinyl benzilate binding. Neurochem Res. 1980;5:301\u20138.","journal-title":"Neurochem Res"},{"key":"1531_CR82","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/0531-5565(83)90020-7","volume":"18","author":"SB Waller","year":"1983","unstructured":"Waller SB, London ED. Age-differences in choline acetyltransferase activities and muscarinic receptor binding in brain regions of C57BL\/6J mice. Exp Gerontol. 1983;18:419\u201325.","journal-title":"Exp Gerontol"},{"key":"1531_CR83","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0197-4580(84)90067-8","volume":"5","author":"NW Pedigo","year":"1984","unstructured":"Pedigo NW, Minor LD, Krumrei TN. Cholinergic drug effects and brain muscarinic receptor binding in aged rats. Neurobiol Aging. 1984;5:227\u201333.","journal-title":"Neurobiol Aging"},{"key":"1531_CR84","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.nbd.2010.10.002","volume":"41","author":"SE Perez","year":"2011","unstructured":"Perez SE, He B, Muhammad N, Oh K-J, Fahnestock M, Ikonomovic MD, et al. Cholinotrophic basal forebrain system alterations in 3xTg-AD transgenic mice. Neurobiol Dis. 2011;41:338\u201352.","journal-title":"Neurobiol Dis"},{"key":"1531_CR85","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/NEN.0b013e31816a1df3","volume":"67","author":"C Geula","year":"2008","unstructured":"Geula C, Nagykery N, Nicholas A, Wu C-K. Cholinergic neuronal and axonal abnormalities are present early in aging and in Alzheimer disease. J Neuropathol Exp Neurol. 2008;67:309\u201318.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1531_CR86","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.neuropsychologia.2013.11.002","volume":"53","author":"D Wolf","year":"2014","unstructured":"Wolf D, Grothe M, Fischer FU, Heinsen H, Kilimann I, Teipel S, et al. Association of basal forebrain volumes and cognition in normal aging. Neuropsychologia 2014;53:54\u201363.","journal-title":"Neuropsychologia"},{"key":"1531_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-95573-8","volume":"11","author":"J Peter","year":"2021","unstructured":"Peter J, Mayer I, Kammer T, Minkova L, Lahr J, Kl\u00f6ppel S, et al. The relationship between cholinergic system brain structure and function in healthy adults and patients with mild cognitive impairment. Sci Rep. 2021;11:16080.","journal-title":"Sci Rep."},{"key":"1531_CR88","doi-asserted-by":"crossref","unstructured":"Wu H, Williams J, Nathans J. Complete morphologies of basal forebrain cholinergic neurons in the mouse. ELife. 2014;3:e02444.","DOI":"10.7554\/eLife.02444"},{"key":"1531_CR89","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1093\/brain\/awaa012","volume":"143","author":"S Fern\u00e1ndez-Cabello","year":"2020","unstructured":"Fern\u00e1ndez-Cabello S, Kronbichler M, Van Dijk KRA, Goodman JA, Spreng RN, Schmitz TW. Basal forebrain volume reliably predicts the cortical spread of Alzheimer\u2019s degeneration. Brain 2020;143:993\u20131009.","journal-title":"Brain"},{"key":"1531_CR90","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.brainresrev.2004.09.003","volume":"48","author":"H Wang","year":"2005","unstructured":"Wang H, Sun X. Desensitized nicotinic receptors in brain. Brain Res Brain Res Rev. 2005;48:420\u201337.","journal-title":"Brain Res Brain Res Rev"},{"key":"1531_CR91","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.pneurobio.2007.12.005","volume":"84","author":"MR Picciotto","year":"2008","unstructured":"Picciotto MR, Addy NA, Mineur YS, Brunzell DH. It\u2019s not \u201ceither\/or\u201d: activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood. Prog Neurobiol. 2008;84:329\u201342.","journal-title":"Prog Neurobiol"},{"key":"1531_CR92","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuropharm.2015.01.022","volume":"96","author":"BJ Henderson","year":"2015","unstructured":"Henderson BJ, Lester HA. Inside-out neuropharmacology of nicotinic drugs. Neuropharmacology 2015;96:178\u201393.","journal-title":"Neuropharmacology"},{"key":"1531_CR93","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.bcp.2011.05.001","volume":"82","author":"DK Williams","year":"2011","unstructured":"Williams DK, Wang J, Papke RL. Positive allosteric modulators as an approach to nicotinic acetylcholine receptor- targeted therapeutics: advantages and limitations. Biochem Pharm. 2011;82:915\u201330.","journal-title":"Biochem Pharm"},{"key":"1531_CR94","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.neuroscience.2010.09.005","volume":"171","author":"L Wecker","year":"2010","unstructured":"Wecker L, Pollock VV, Pacheco MA, Pastoor T. Nicotine-induced up regulation of \u03b14\u03b2 2 neuronal nicotinic receptors is mediated by the PKC-dependent phosphorylation of \u03b14 subunits. Neuroscience 2010;171:12\u201322.","journal-title":"Neuroscience"},{"key":"1531_CR95","doi-asserted-by":"publisher","first-page":"7886","DOI":"10.1523\/JNEUROSCI.0409-16.2016","volume":"36","author":"Y-G Sun","year":"2016","unstructured":"Sun Y-G, Rupprecht V, Zhou L, Dasgupta R, Seibt F, Beierlein M. mGluR1 and mGluR5 Synergistically Control Cholinergic Synaptic Transmission in the Thalamic Reticular Nucleus. J Neurosci. 2016;36:7886\u201396.","journal-title":"J Neurosci"},{"key":"1531_CR96","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/jnc.14073","volume":"142","author":"GY L\u00f3pez-Hern\u00e1ndez","year":"2017","unstructured":"L\u00f3pez-Hern\u00e1ndez GY, Ananth M, Jiang L, Ballinger EC, Talmage DA, Role LW. Electrophysiological properties of basal forebrain cholinergic neurons identified by genetic and optogenetic tagging. J Neurochem. 2017;142:103\u201310.","journal-title":"J Neurochem"},{"key":"1531_CR97","doi-asserted-by":"publisher","first-page":"10427","DOI":"10.1523\/JNEUROSCI.0395-13.2013","volume":"33","author":"B Kolisnyk","year":"2013","unstructured":"Kolisnyk B, Guzman MS, Raulic S, Fan J, Magalh\u00e3es AC, Feng G, et al. ChAT-ChR2-EYFP mice have enhanced motor endurance but show deficits in attention and several additional cognitive domains. J Neurosci. 2013;33:10427\u201338.","journal-title":"J Neurosci"},{"key":"1531_CR98","doi-asserted-by":"publisher","first-page":"e0272141","DOI":"10.1371\/journal.pone.0272141","volume":"17","author":"C Lhopitallier","year":"2022","unstructured":"Lhopitallier C, Perrault C, Chauveau F, Saurini F, Berrard S, Granon S, et al. Characterization of social behavior in young and middle-aged ChAT-IRES-Cre mouse. PloS ONE. 2022;17:e0272141.","journal-title":"PloS ONE"},{"key":"1531_CR99","doi-asserted-by":"publisher","first-page":"eaax6646","DOI":"10.1126\/sciadv.aax6646","volume":"6","author":"K Xhima","year":"2020","unstructured":"Xhima K, Markham-Coultes K, Nedev H, Heinen S, Saragovi HU, Hynynen K, et al. Focused ultrasound delivery of a selective TrkA agonist rescues cholinergic function in a mouse model of Alzheimer\u2019s disease. Sci Adv. 2020;6:eaax6646.","journal-title":"Sci Adv"},{"key":"1531_CR100","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1002\/hipo.22732","volume":"27","author":"CA Thorn","year":"2017","unstructured":"Thorn CA, Popiolek M, Stark E, Edgerton JR. Effects of M1 and M4 activation on excitatory synaptic transmission in CA1. Hippocampus 2017;27:794\u2013810.","journal-title":"Hippocampus"},{"key":"1531_CR101","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/s41386-020-00916-0","volume":"46","author":"C Montani","year":"2021","unstructured":"Montani C, Canella C, Schwarz AJ, Li J, Gilmour G, Galbusera A, et al. The M1\/M4 preferring muscarinic agonist xanomeline modulates functional connectivity and NMDAR antagonist-induced changes in the mouse brain. Neuropsychopharmacology 2021;46:1194\u2013206.","journal-title":"Neuropsychopharmacology"},{"key":"1531_CR102","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0006-8993(94)90365-4","volume":"653","author":"JN Larocca","year":"1994","unstructured":"Larocca JN, Rodriguez-Gabin AG, Rashbaum WK, Weidenheim KM, Lyman WD. Muscarinic receptor-dependent activation of phospholipase C in the developing human fetal central nervous system. Brain Res. 1994;653:9\u201315.","journal-title":"Brain Res"},{"key":"1531_CR103","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3389\/fphar.2019.00343","volume":"10","author":"JM Miwa","year":"2019","unstructured":"Miwa JM, Anderson KR, Hoffman KM. Lynx Prototoxins: Roles of Endogenous Mammalian Neurotoxin-Like Proteins in Modulating Nicotinic Acetylcholine Receptor Function to Influence Complex Biological Processes. Front Pharm. 2019;10:343.","journal-title":"Front Pharm"},{"key":"1531_CR104","doi-asserted-by":"crossref","unstructured":"Venkatesan S, Chen T, Liu Y, Turner EE, Tripathy S, Lambe EK. Chrna5 and lynx prototoxins identify acetylcholine super-responder subplate neurons. bioRxiv 2022; 2022.06.20.496737.","DOI":"10.1101\/2022.06.20.496737"},{"key":"1531_CR105","doi-asserted-by":"publisher","first-page":"4477","DOI":"10.1073\/pnas.0813109106","volume":"106","author":"AB Tekinay","year":"2009","unstructured":"Tekinay AB, Nong Y, Miwa JM, Lieberam I, Ibanez-Tallon I, Greengard P, et al. A role for LYNX2 in anxiety-related behavior. Proc Natl Acad Sci USA 2009;106:4477\u201382.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1531_CR106","doi-asserted-by":"publisher","first-page":"24509","DOI":"10.1074\/jbc.M115.647248","volume":"290","author":"M Wu","year":"2015","unstructured":"Wu M, Puddifoot CA, Taylor P, Joiner WJ. Mechanisms of Inhibition and Potentiation of \u03b14\u03b22 Nicotinic Acetylcholine Receptors by Members of the Ly6 Protein Family. J Biol Chem. 2015;290:24509\u201318.","journal-title":"J Biol Chem"},{"key":"1531_CR107","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-68947-7","volume":"10","author":"Y Moriwaki","year":"2020","unstructured":"Moriwaki Y, Kubo N, Watanabe M, Asano S, Shinoda T, Sugino T, et al. Endogenous neurotoxin-like protein Ly6H inhibits alpha7 nicotinic acetylcholine receptor currents at the plasma membrane. Sci Rep. 2020;10:11996.","journal-title":"Sci Rep."},{"key":"1531_CR108","doi-asserted-by":"publisher","first-page":"3420","DOI":"10.1523\/JNEUROSCI.3630-14.2015","volume":"35","author":"CA Puddifoot","year":"2015","unstructured":"Puddifoot CA, Wu M, Sung R-J, Joiner WJ. Ly6h Regulates Trafficking of Alpha7 Nicotinic Acetylcholine Receptors and Nicotine-Induced Potentiation of Glutamatergic Signaling. J Neurosci. 2015;35:3420\u201330.","journal-title":"J Neurosci"},{"key":"1531_CR109","doi-asserted-by":"publisher","first-page":"31423","DOI":"10.1074\/jbc.M114.573667","volume":"289","author":"WA Nichols","year":"2014","unstructured":"Nichols WA, Henderson BJ, Yu C, Parker RL, Richards CI, Lester HA, et al. Lynx1 Shifts \u03b14\u03b22 Nicotinic Receptor Subunit Stoichiometry by Affecting Assembly in the Endoplasmic Reticulum. J Biol Chem. 2014;289:31423\u201332.","journal-title":"J Biol Chem"},{"key":"1531_CR110","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/(SICI)1098-2299(199702)40:2<158::AID-DDR6>3.0.CO;2-K","volume":"40","author":"FP Bymaster","year":"1997","unstructured":"Bymaster FP, Whitesitt CA, Shannon HE, DeLapp N, Ward JS, Calligaro DO, et al. Xanomeline: a selective muscarinic agonist for the treatment of Alzheimer\u2019s disease. Drug Dev Res. 1997;40:158\u201370.","journal-title":"Drug Dev Res"},{"key":"1531_CR111","doi-asserted-by":"crossref","unstructured":"Weiden PJ, Breier A, Kavanagh S, Miller AC, Brannan SK, Paul SM. Antipsychotic Efficacy of KarXT (Xanomeline-Trospium): Post Hoc Analysis of Positive and Negative Syndrome Scale Categorical Response Rates, Time Course of Response, and Symptom Domains of Response in a Phase 2 Study. J Clin Psychiatry. 2022;83:21m14316.","DOI":"10.4088\/JCP.21m14316"},{"key":"1531_CR112","doi-asserted-by":"publisher","first-page":"5886","DOI":"10.1016\/j.cell.2021.11.001","volume":"184","author":"AJH Brown","year":"2021","unstructured":"Brown AJH, Bradley SJ, Marshall FH, Brown GA, Bennett KA, Brown J, et al. From structure to clinic: design of a muscarinic M1 receptor agonist with potential to treatment of Alzheimer\u2019s disease. Cell. 2021;184:5886\u20135901.e22.","journal-title":"Cell"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41386-023-01531-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-023-01531-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-023-01531-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T11:06:37Z","timestamp":1676631997000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-023-01531-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,12]]},"references-count":112,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["1531"],"URL":"https:\/\/doi.org\/10.1038\/s41386-023-01531-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.09.29.510152","asserted-by":"object"}]},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,12]]},"assertion":[{"value":"29 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}